The core activity of Redbiotec AG is the development and production of key proteins and genetic materials for the biopharmaceutical and food industries. The company focuses on the research and development of therapeutic bacteria for the treatment of cancer and genetic diseases.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentPharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Key proteins and genetic materials for biopharma and food industry, including protein expression and cell-free manufacturing of DNA products such as pDNA and mRNA templates.
Casein proteins
Engineering yeast and bacteria to produce casein proteins for animal-free milk and other dairy products, including kappa casein expression and scale-up development.
Cell-free manufacturing of genetic materials
Cell-free manufacturing of genetic materials such as pDNA and templates for mRNA manufacturing, with fast and cost-efficient DNA product production and microfluidics collaboration.
Therapeutic vaccine development
Development of vaccines to fight difficult diseases, including therapeutic vaccine programs based on preclinical research and immunotherapy approaches.
HSV-2 therapeutic vaccine program
HSV-2 therapeutic vaccine development with T-cell-mediated protection, preclinical efficacy data and a two-injection immunotherapy approach.